| Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial RJ Cox, G Pedersen, AS Madhun, S Svindland, M Sævik, L Breakwell, ... Vaccine 29 (45), 8049-8059, 2011 | 121 | 2011 |
| Immunocorrelates of CAF family adjuvants GK Pedersen, P Andersen, D Christensen Seminars in immunology 39, 4-13, 2018 | 85 | 2018 |
| Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP GK Pedersen, T Ebensen, IH Gjeraker, S Svindland, G Bredholt, ... PloS one 6 (11), e26973, 2011 | 78 | 2011 |
| Modulation of immune responses using adjuvants to facilitate therapeutic vaccination V Schijns, A Fernández‐Tejada, Ž Barjaktarović, I Bouzalas, J Brimnes, ... Immunological reviews 296 (1), 169-190, 2020 | 75 | 2020 |
| An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers AS Madhun, PE Akselsen, H Sjursen, G Pedersen, S Svindland, ... Vaccine 29 (2), 266-273, 2010 | 68 | 2010 |
| A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo L Hanke, H Das, DJ Sheward, L Perez Vidakovics, E Urgard, ... Nature communications 13 (1), 155, 2022 | 67 | 2022 |
| Mucosal administration of cycle-di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in mice T Ebensen, J Debarry, GK Pedersen, P Blazejewska, S Weissmann, ... Frontiers in immunology 8, 1223, 2017 | 56 | 2017 |
| T-helper 1 cells elicited by H5N1 vaccination predict seroprotection GK Pedersen, AS Madhun, L Breakwell, K Hoschler, H Sjursen, ... The Journal of infectious diseases 206 (2), 158-166, 2012 | 56 | 2012 |
| B-1a transitional cells are phenotypically distinct and are lacking in mice deficient in IκBNS GK Pedersen, M Àdori, S Khoenkhoen, P Dosenovic, B Beutler, ... Proceedings of the National Academy of Sciences 111 (39), E4119-E4126, 2014 | 53 | 2014 |
| Vaccine adjuvants differentially affect kinetics of antibody and germinal center responses GK Pedersen, K Wørzner, P Andersen, D Christensen Frontiers in immunology 11, 579761, 2020 | 52 | 2020 |
| The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza G Pedersen, R Cox Human vaccines & immunotherapeutics 8 (5), 689-693, 2012 | 47 | 2012 |
| Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination GK Pedersen, K Höschler, SMØ Solbak, G Bredholt, RD Pathirana, ... Vaccine 32 (35), 4550-4557, 2014 | 44 | 2014 |
| Pandemic Influenza Vaccination Elicits Influenza‐Specific CD4+ Th1‐cell Responses in Hypogammaglobulinaemic Patients: Four case reports G Pedersen, A Halstensen, H Sjursen, A Naess, EK Kristoffersen, RJ Cox Scandinavian journal of immunology 74 (2), 210-218, 2011 | 44 | 2011 |
| A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine SC Svindland, GK Pedersen, RD Pathirana, G Bredholt, JK Nøstbakken, ... Influenza and other respiratory viruses 7 (6), 1181-1193, 2013 | 42 | 2013 |
| Matrix‐M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model G Pedersen, D Major, S Roseby, J Wood, AS Madhun, RJ Cox Influenza and Other Respiratory Viruses 5 (6), 426-437, 2011 | 42 | 2011 |
| Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice K Wørzner, DJ Sheward, ST Schmidt, L Hanke, J Zimmermann, ... EBioMedicine 63, 2021 | 39 | 2021 |
| Matrix MTM adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4+ T cell responses in man GK Pedersen, H Sjursen, JK Nøstbakken, Å Jul-Larsen, K Hoschler, ... Human vaccines & immunotherapeutics 10 (8), 2408-2416, 2014 | 33 | 2014 |
| Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to … A Wilkinson, E Lattmann, CB Roces, GK Pedersen, D Christensen, ... Journal of Controlled Release 291, 1-10, 2018 | 26 | 2018 |
| Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy D Christensen, C Polacek, DJ Sheward, L Hanke, A Moliner-Morro, ... EBioMedicine 84, 2022 | 24 | 2022 |
| Induction of cytotoxic T-lymphocyte responses upon subcutaneous administration of a subunit vaccine adjuvanted with an emulsion containing the toll-like receptor 3 ligand poly … ST Schmidt, GK Pedersen, MA Neustrup, KS Korsholm, T Rades, ... Frontiers in immunology 9, 898, 2018 | 19 | 2018 |
